📋 Tender Overview
Contract awarded for Framework agreement for the supply of oncology medications for 48 months lot-0001, title: azacitidine 25mg/ml, description: according to the document "06 centralizer of minimum and maximum estimated values for medicines 48 months.xlsx.p7s" lot-0003, title: deferasirox (reditens) 360 mg, description: according to the document "06 centralizer of minimum and maximum estimated values for medicines 48 months.xlsx.p7s" lot-0004, title: carboplatin 10 mg/ml - 150mg, description: according to the document "06 centralizer of minimum and maximum estimated values for medicines 48 months.xlsx.p7s" lot-0005, title: doxorubicin 2 mg/ml - 25 ml, description: according to the document "06 centralizer of minimum and maximum estimated values for medicines 48 months.xlsx.p7s" lot-0010, title: recombinant factor viii 500ui with trehalose (octocog alfa) / advate, description: according to the document "06 centralizer of minimum and maximum estimated values for medicines 48 months.xlsx.p7s" lot-0012, title: fluorouracil 50 mg/ml - 20 ml, description: according to the document "06 centralizer of minimum and maximum estimated values for medicines 48 months.xlsx.p7s" lot-0016, title: methotrexate 10mg/ml ser 1.5 ml, description: according to the document "06 centralizer of minimum and maximum estimated values for medicines 48 months.xlsx.p7s" lot-0017, title: temozolomide 100 mg, description: according to the document "06 centralizer of minimum and maximum estimated values for medicines 48 months.xlsx.p7s" estimated value excluding vat: 19252.80 ron.Framework agreement for the supply of oncology medications for 48 months
